GlobeNewswire Inc.··NaIpsen's First-in-Class Corabotase Shows Promise in Phase II Wrinkle Trial
Ipsen unveiled Phase II data for corabotase, a first-in-class recombinant neuro-inhibitor, showing rapid onset and sustained benefits for wrinkles at SCALE 2026 symposium.
IPSEYPhase II trialaesthetic medicine